v3.26.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
EBP, PR  
EBP, Investment, Fair Value and NAV [Line Items]  
Schedule of Plan Investments at Fair Value
The following tables set forth by level, within the fair value hierarchy, the Plan’s investments at fair value:
Fair Value as of December 31, 2025
(THOUSANDS OF DOLLARS)
Level 1
Level 2
Total
Pfizer Inc. common stock
$37,889 $— $37,889 
Common/collective trust funds
— 337,363 337,363 
Mutual funds
13,239 — 13,239 
Separate account:
Common stock
30,193 — 30,193 
Common/collective trust funds
— 869 869 
Other
978 — 978 
   Total
$82,299 $338,232 $420,531 
Fair Value as of December 31, 2024
(THOUSANDS OF DOLLARS)
Level 1
Level 2
Total
Pfizer Inc. common stock
$41,341 $— $41,341 
Common/collective trust funds
— 305,953 305,953 
Mutual funds
15,540 — 15,540 
Separate account:
Common stock
28,941 — 28,941 
Common/collective trust funds
— 791 791 
Other
543 — 543 
   Total
$86,365 $306,745 $393,110 
Amounts may not add due to rounding